Literature DB >> 11394968

Prediction of neuropsychiatric outcome following mild trauma brain injury: an examination of the Glasgow Coma Scale.

S McCullagh1, D Oucherlony, A Protzner, N Blair, A Feinstein.   

Abstract

The relationship between the Glasgow Coma Scale (GCS) and neuropsychiatric outcome was examined in 57 consecutive subjects with mild traumatic brain injury (TBI) attending a follow-up clinic. Subjects were grouped according to initial GCS score (15 versus 13-14) and contrasted at an average of 5-6 months post-injury. As expected, those with GCS 13-14 had longer PTA (p = 0.001) and a higher rate of abnormal brain CT scans (p = 0.005). However, no significant differences emerged for indices of neuropsychiatric status, including measures of neurobehavioural symptoms/signs, overall psychological distress, psychiatric 'caseness', functional and psychosocial outcome, frequency of common somatic complaints, and rate of return to work. Subsidiary analyses based upon the presence/absence of CT abnormalities and the duration of PTA (<1 hour versus 1-24 hours) also failed to predict outcome, although a trend associating longer PTA with lower functional outcome was observed. Thus, despite early neurosurgical differences, the results suggest that initial GCS scores do not clearly translate into neuropsychiatric sequelae at follow-up within the rubric of GCS 13-15.

Entities:  

Mesh:

Year:  2001        PMID: 11394968     DOI: 10.1080/02699050010007353

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  12 in total

1.  Causes and outcomes of mild traumatic brain injury: an analysis of CIREN data.

Authors:  P Dischinger; K Read; T Kerns; S Ho; J Kufera; C Burch; N Jawed; A Burgess; F Bents
Journal:  Annu Proc Assoc Adv Automot Med       Date:  2003

2.  Outcome after mild traumatic brain injury: an examination of recruitment bias.

Authors:  S McCullagh; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 3.  Biomarkers in traumatic brain injury.

Authors:  Richa Sharma; Daniel T Laskowitz
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

4.  Recovery from mild traumatic brain injury: a focus on fatigue.

Authors:  Maja Stulemeijer; Sieberen van der Werf; Gijs Bleijenberg; Jan Biert; Jolanda Brauer; Pieter E Vos
Journal:  J Neurol       Date:  2006-05-17       Impact factor: 4.849

5.  Sex differences in outcome after mild traumatic brain injury.

Authors:  Jeffrey J Bazarian; Brian Blyth; Sohug Mookerjee; Hua He; Michael P McDermott
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

6.  Frontiers in the pathogenesis of Alzheimer's disease.

Authors:  Kumar Sambamurti; K S Jagannatha Rao; Miguel A Pappolla
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

7.  Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

Authors:  David B Arciniegas; C Alan Anderson; Jeannie Topkoff; Thomas W McAllister
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

Review 8.  Neuroimaging after mild traumatic brain injury: review and meta-analysis.

Authors:  Cyrus Eierud; R Cameron Craddock; Sean Fletcher; Manek Aulakh; Brooks King-Casas; Damon Kuehl; Stephen M LaConte
Journal:  Neuroimage Clin       Date:  2014-01-04       Impact factor: 4.881

9.  Orbitofrontal cortical thinning and aggression in mild traumatic brain injury patients.

Authors:  Daniel J Epstein; Margaret Legarreta; Elliot Bueler; Jace King; Erin McGlade; Deborah Yurgelun-Todd
Journal:  Brain Behav       Date:  2016-09-28       Impact factor: 2.708

10.  Predicting Outcome 12 Months after Mild Traumatic Brain Injury in Patients Admitted to a Neurosurgery Service.

Authors:  Torgeir Hellstrøm; Tobias Kaufmann; Nada Andelic; Helene L Soberg; Solrun Sigurdardottir; Eirik Helseth; Ole A Andreassen; Lars T Westlye
Journal:  Front Neurol       Date:  2017-04-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.